{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:20:46Z","timestamp":1779081646737,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government","award":["2015R1A5A1008958"],"award-info":[{"award-number":["2015R1A5A1008958"]}]},{"DOI":"10.13039\/501100003663","name":"Korea Small and Medium Business Administration","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015826","name":"Korean Society of Ginseng","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015826","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Korea Ginseng Cooperation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jgr.2017.08.008","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T16:51:12Z","timestamp":1505407872000},"page":"370-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of Korean Red Ginseng extracts on drug-drug interactions"],"prefix":"10.1016","volume":"42","author":[{"given":"Se-Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungmok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyu-Lee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-On","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonku","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Kwon","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgr.2017.08.008_bib1","first-page":"259","article-title":"Cancer prevention and therapeutics: Panax ginseng","volume":"9","author":"Helms","year":"2004","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.jgr.2017.08.008_bib2","first-page":"1","article-title":"Ginsenosides chemistry, biosynthesis, analysis, and potential health effects","volume":"55","author":"Christensen","year":"2009","journal-title":"Adv Food Nutr Res"},{"key":"10.1016\/j.jgr.2017.08.008_bib3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1248\/bpb.26.858","article-title":"Effect of ginsenosides administered intrathecally on the antinociception induced by cold water swimming stress in the mouse","volume":"26","author":"Choi","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jgr.2017.08.008_bib4","first-page":"1057","article-title":"Constituents and pharmacological effects of Eucommia and Siberian ginseng","volume":"22","author":"Deyama","year":"2001","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jgr.2017.08.008_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/exnr.2001.7841","article-title":"Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in\u00a0vitro","volume":"173","author":"Liao","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jgr.2017.08.008_bib6","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.3346\/jkms.2001.16.S.S66","article-title":"Cancer chemoprevention by ginseng in mouse liver and other organs","volume":"16","author":"Nishino","year":"2001","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jgr.2017.08.008_bib7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1211\/0022357011777882","article-title":"Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium)","volume":"53","author":"Wang","year":"2001","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejps.2005.11.002","article-title":"The role of transporters in drug interactions","volume":"27","author":"Endres","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jgr.2017.08.008_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1146\/annurev.pharmtox.44.101802.121444","article-title":"Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs","volume":"45","author":"Shitara","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"Suppl 2","key":"10.1016\/j.jgr.2017.08.008_bib10","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/00004836-199000000-00010","article-title":"The clinical importance of drug interactions with antiulcer therapy","volume":"12","author":"Reynolds","year":"1990","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jgr.2017.08.008_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003088-197601050-00003","article-title":"Drug interactions and clinical pharmacokinetics","volume":"1","author":"Kristensen","year":"1976","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jgr.2017.08.008_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2036.1999.00021.x","article-title":"Review article: drug interactions with agents used to treat acid-related diseases","volume":"13","author":"Humphries","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jgr.2017.08.008_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00002826-199402000-00003","article-title":"Pharmacodynamic interactions between phenytoin and valproate: individual and combined antiepileptic and neurotoxic actions in mice","volume":"17","author":"Chez","year":"1994","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/dmd.113.055558","article-title":"Understanding the transport properties of metabolites: case studies and considerations for drug development","volume":"42","author":"Zamek-Gliszczynski","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jgr.2017.08.008_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2165\/00002018-199512030-00003","article-title":"Antineoplastic agents - drug-interactions of clinical-significance","volume":"12","author":"Vanmeerten","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.jgr.2017.08.008_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2010.02.007","article-title":"Therapeutic implications of renal anionic drug transporters","volume":"126","author":"Masereeuw","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jgr.2017.08.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.693","article-title":"Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology","volume":"31","author":"VanWert","year":"2010","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jgr.2017.08.008_bib18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"Koepsell","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jgr.2017.08.008_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.jgr.2017.08.008_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2125.2000.00132.x","article-title":"Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine","volume":"49","author":"Fattinger","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s002280000158","article-title":"Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne\/St. Gallen","volume":"56","author":"Zoppi","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","article-title":"Inhibition and induction of cytochrome P450 and the clinical implications","volume":"35","author":"Lin","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jgr.2017.08.008_bib23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mcp.2000.112240","article-title":"St John's Wort induces intestinal P-glycoprotein\/MDR1 and intestinal and hepatic CYP3A4","volume":"68","author":"Durr","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jgr.2017.08.008_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2165\/00003088-199732030-00004","article-title":"Use of in\u00a0vitro and in\u00a0vivo data to estimate the likelihood of metabolic pharmacokinetic interactions","volume":"32","author":"Bertz","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jgr.2017.08.008_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03602539709037591","article-title":"Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors","volume":"29","author":"Rendic","year":"1997","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jgr.2017.08.008_bib26","doi-asserted-by":"crossref","first-page":"PL209","DOI":"10.1016\/S0024-3205(99)00407-5","article-title":"Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity","volume":"65","author":"Henderson","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.jgr.2017.08.008_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/toxsci\/kfj164","article-title":"Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes","volume":"91","author":"Liu","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jgr.2017.08.008_bib28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1248\/jhs.55.809","article-title":"Ginseng extracts facilitate cytochrome p450 xenobiotic metabolism in primary cultures of rat hepatocytes","volume":"55","author":"Kawase","year":"2009","journal-title":"J\u00a0Health Sci"},{"key":"10.1016\/j.jgr.2017.08.008_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2008.10.057","article-title":"Induction of cytochrome P450 1A1 expression by ginsenoside Rg1 and Rb1 in HepG2 cells","volume":"601","author":"Wang","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12272-001-1137-y","article-title":"Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation","volume":"31","author":"Kwon","year":"2008","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jgr.2017.08.008_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jgr.2015.11.005","article-title":"Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers","volume":"40","author":"Kim","year":"2016","journal-title":"J\u00a0Ginseng Res"},{"key":"10.1016\/j.jgr.2017.08.008_bib32","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/bcp.13080","article-title":"Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach","volume":"82","author":"Kim","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/0091270011407194","article-title":"Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants","volume":"52","author":"Malati","year":"2012","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1345\/aph.1M715","article-title":"Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity","volume":"44","author":"Bilgi","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jgr.2017.08.008_bib35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.lungcan.2008.11.016","article-title":"Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD","volume":"65","author":"Wang","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jgr.2017.08.008_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.phymed.2009.03.014","article-title":"Comparative research of chemical constituents, antifungal and antitumor properties of ether extracts of Panax ginseng and its endophytic fungus","volume":"16","author":"Xu","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2017.08.008_bib37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0090-9556(24)15071-4","article-title":"Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures","volume":"28","author":"Venkataramanan","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jgr.2017.08.008_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2125.2000.00283.x","article-title":"Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine","volume":"50","author":"Vincent","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0009-9236(01)00127-8","article-title":"The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity","volume":"70","author":"Wang","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jgr.2017.08.008_bib40","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1345\/aph.10031","article-title":"Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence","volume":"34","author":"Vaes","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jgr.2017.08.008_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.42.111901.111051","article-title":"Regulation of cyp3a gene transcription by the pregnane x receptor","volume":"42","author":"Goodwin","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jgr.2017.08.008_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-199602000-00002","article-title":"P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature","volume":"6","author":"Nelson","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jgr.2017.08.008_bib43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2133\/dmpk.DMPK-10-NT-056","article-title":"Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A4 expression in HepG2 cells than glycosylated ginsenosides","volume":"26","author":"Hao","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jgr.2017.08.008_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2010.05.017","article-title":"Induction of CYP3A4 and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways","volume":"640","author":"Li","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jgr.2017.08.008_bib45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1124\/dmd.30.4.378","article-title":"In\u00a0vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1","volume":"30","author":"Chang","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jgr.2017.08.008_bib46","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.lfs.2003.07.035","article-title":"Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL\/6J but not in DBA\/2J mice","volume":"74","author":"Ueng","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.jgr.2017.08.008_bib47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00216-008-2291-6","article-title":"Functional pharmacogenetics\/genomics of human cytochromes P450 involved in drug biotransformation","volume":"392","author":"Zanger","year":"2008","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jgr.2017.08.008_bib48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.jgr.2017.08.008_bib49","doi-asserted-by":"crossref","first-page":"32570","DOI":"10.1074\/jbc.M800298200","article-title":"Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathway","volume":"283","author":"Zhang","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jgr.2017.08.008_bib50","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.00528.2007","article-title":"Overlapping in\u00a0vitro and in\u00a0vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics","volume":"294","author":"Vallon","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jgr.2017.08.008_bib51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/hmg\/ddp489","article-title":"Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms","volume":"19","author":"van der Harst","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jgr.2017.08.008_bib52","first-page":"93","article-title":"Fexofenadina: nuevo antihistaminico. Revision de sus caracteristicas practicas [Fexofenadine: a antihistaminic. Review of its practical characteristics]","volume":"43","author":"Caballero","year":"1999","journal-title":"Rev Med Univ Navarra"},{"key":"10.1016\/j.jgr.2017.08.008_bib53","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1023\/A:1018877803319","article-title":"Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein","volume":"16","author":"Kim","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.jgr.2017.08.008_bib54","article-title":"Guidance for industry: Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers","author":"Research CfDEa","year":"2005","journal-title":"Center for Drug Evaluation and Research"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845317301690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845317301690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:11:11Z","timestamp":1761124271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1226845317301690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1226845317301690"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2017.08.008","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Korean Red Ginseng extracts on drug-drug interactions","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2017.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.","name":"copyright","label":"Copyright"}]}}